Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of human umbilical cord mesenchymal stem cell injection in moderate-to-severe active inflammatory bowel disease
CTR20252473Phase 2Active
- Sponsor
- Yiwen Cell
- Start
- Nov 2025
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cell in inflammatory bowel disease (IBD), autoimmune colitis, Crohn's disease, sponsored by Yiwen Cell. Started Nov 2025; status: active.
02
Drugs
human umbilical cord mesenchymal stem cell
03
Conditions
inflammatory bowel disease (IBD)autoimmune colitisCrohn's disease
Beyond the preview
Go deeper on CTR20252473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252473.